Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Cancer Control : Journal of the Moffitt Cancer Center|December 19, 2015
Palliative Sedation in Patients With CancerMarco Maltoni, Elisabetta SetolaJournal of Cancer Research and Therapeutics|June 14, 2021
Complementary and alternative medicine in sarcoma patients treated in an Italian sarcoma centerAlessandra Longhi, Elisabetta Setola, Cristina Ferrari, et al.Future Oncology (London, England)|December 21, 2019
Experience with eribulin in pretreated patients with advanced liposarcoma: a case seriesAnna Paioli, Elisabetta Setola, Emanuela Palmerini, et al.Expert Review of Anticancer Therapy|June 17, 2017
Eribulin in advanced liposarcoma and leiomyosarcomaElisabetta Setola, Jonathan Noujaim, Charlotte Benson, et al.Cancer|April 28, 2004
Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcomaStefano Ferrari, Franco Bertoni, Licciana Zanella, et al.Journal of Cellular Physiology|January 6, 2015
Generation of tumor-specific cytotoxic T-lymphocytes from the peripheral blood of colorectal cancer patients for adoptive T-cell transferSilvia Carluccio, Serena Delbue, Lucia Signorini, et al.Journal of Pediatric Hematology/Oncology|November 11, 2003
Neoadjuvant chemotherapy for osteosarcoma of the extremity: intensification of preoperative treatment does not increase the rate of good histologic response to the primary tumor or improve the final outcomeGaetano Bacci, Cristiana Forni, Stefano Ferrari, et al.Pediatric Blood & Cancer|May 7, 2019
Is there a role for chemotherapy after local relapse in high-grade osteosarcoma?Emanuela Palmerini, Elisa Torricelli, Stefano Cascinu, et al.The Oncologist|May 8, 2024
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysisLuca Boscolo Bielo, Matteo Repetto, Edoardo Crimini, et al.Clinical Orthopaedics and Related Research|May 21, 2020
How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?Michiel E R Bongers, Aditya V Karhade, Elisabetta Setola, et al.Pageof 2